Basal cell carcinoma - Basalis Cellula Carcinoma
☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Laesiones exulceratae quae cutem narium in singulis senibus afficiunt saepe dignoscuntur sicut Basalis Cellula Carcinoma (Basal cell carcinoma). Nasus communis locus occurrentis est ad hoc genus cancere cutis.
Basalis Cellula Carcinoma (Basal cell carcinoma) terminis irregularibus et ulceribus exhibere possint.
Basalis Cellula Carcinoma (Basal cell carcinoma) verruca falli potest.
References
Basal cell carcinoma (BCC) Est frequentissimum genus cancere cutis. Solis nulla causa est principalis. Fere omnes BCC casus ericatrices hedgehog ostendunt signum in analysi hypothetica. Variae curationes praesto sunt et electae secundum recursu periculum, momentum textus conservationis, patientis praeferentiae, et amplitudo morbi.
Basal cell carcinoma (BCC) is the most common malignancy. Exposure to sunlight is the most important risk factor. Most, if not all, cases of BCC demonstrate overactive Hedgehog signaling. A variety of treatment modalities exist and are selected based on recurrence risk, importance of tissue preservation, patient preference, and extent of disease.
Basal cell carcinoma (BCC) is the most common malignancy. Exposure to sunlight is the most important risk factor. Most, if not all, cases of BCC demonstrate overactive Hedgehog signaling. A variety of treatment modalities exist and are selected based on recurrence risk, importance of tissue preservation, patient preference, and extent of disease.
Basal cell carcinomas Frequentissima sunt cancri cutis in adultis pulchre-cutis 50 et supra longis. Eorum numeros in orbem terrarum oriuntur, maxime ob expositionem solis. Quaedam condiciones geneticae facile possunt efficere ut haec carcinomata in minore aetate enucleentur. Basal cell carcinomas In severitate variantur, ex facili tractabili laesiones superficiales vel nodulares ad ampliora quae discussionem requirunt in specialibus iunctionibus medicis. Prognosis pendet a probabilitate cancri reddendi vel eius facultatem laedendi prope textus. Surgeria est norma curatio in pluribus casibus, praecise remotionis et casus humilitatis recurrentis. Modi incursivi minus efficaciter laesiones superficiales tractare possunt.
Basal cell carcinomas are the most frequent skin cancers in the fair-skinned adult population over 50 years of age. Their incidence is increasing throughout the world. Ultraviolet (UV) exposure is the major carcinogenic factor. Some genodermatosis can predispose to formation of basal cell carcinomas at an earlier age. Basal cell carcinomas are heterogeneous, from superficial or nodular lesions of good prognosis to very extensive difficult-to-treat lesions that must be discussed in multidisciplinary committees. The prognosis is linked to the risk of recurrence of basal cell carcinoma or its local destructive capacity. The standard treatment for most basal cell carcinomas is surgery, as it allows excision margin control and shows a low risk of recurrence. Superficial lesions can be treated by non-surgical methods with significant efficacy.
Basal cell carcinomas are the most frequent skin cancers in the fair-skinned adult population over 50 years of age. Their incidence is increasing throughout the world. Ultraviolet (UV) exposure is the major carcinogenic factor. Some genodermatosis can predispose to formation of basal cell carcinomas at an earlier age. Basal cell carcinomas are heterogeneous, from superficial or nodular lesions of good prognosis to very extensive difficult-to-treat lesions that must be discussed in multidisciplinary committees. The prognosis is linked to the risk of recurrence of basal cell carcinoma or its local destructive capacity. The standard treatment for most basal cell carcinomas is surgery, as it allows excision margin control and shows a low risk of recurrence. Superficial lesions can be treated by non-surgical methods with significant efficacy.
Curatio prima BCC chirurgica est. Pro magno periculo vel BCC frequentissima, praesertim in locis criticis, micrographice chirurgia moderata commendatur. Aegris cum humili periculo superficiali BCC tractationes topicas vel modos perniciosos considerare posset. Lorem photodynamica bene operatur ad periculum nodulare superficialis et humilis BCCs. Pro localiter provecto vel metastatico BCC, Hedgehog inhibitores (vismodegib, sonidegib) commendantur. Si morbus progressio vel intolerantia inhibentium Hedgehog est, immunotherapy cum anti-PD1 antibody (cemiplimab) considerari potest. Radiotherapia optima est optio aegris qui chirurgicam habere non possunt, praesertim aegros maiores. Electrochemotherapy considerari potest si chirurgia vel radiotherapia optionis non est.
The primary treatment for BCC is surgery. For high-risk or recurring BCC, especially in critical areas, micrographically controlled surgery is recommended. Patients with low-risk superficial BCC might consider topical treatments or destructive methods. Photodynamic therapy works well for superficial and low-risk nodular BCCs. For locally advanced or metastatic BCC, Hedgehog inhibitors (vismodegib, sonidegib) are recommended. If there's disease progression or intolerance to Hedgehog inhibitors, immunotherapy with anti-PD1 antibody (cemiplimab) can be considered. Radiotherapy is a good option for patients who can't have surgery, especially older patients. Electrochemotherapy could be considered if surgery or radiotherapy isn't an option.
The primary treatment for BCC is surgery. For high-risk or recurring BCC, especially in critical areas, micrographically controlled surgery is recommended. Patients with low-risk superficial BCC might consider topical treatments or destructive methods. Photodynamic therapy works well for superficial and low-risk nodular BCCs. For locally advanced or metastatic BCC, Hedgehog inhibitors (vismodegib, sonidegib) are recommended. If there's disease progression or intolerance to Hedgehog inhibitors, immunotherapy with anti-PD1 antibody (cemiplimab) can be considered. Radiotherapy is a good option for patients who can't have surgery, especially older patients. Electrochemotherapy could be considered if surgery or radiotherapy isn't an option.
Periculi factores nuditatem includunt ad lucem ultravioletam, radialem justo, diuturnum expositionem ad munus arsenicum et pauperes immune systematis (v.g. organi transplantationis). Patefacio ad UV lucem in adulescentia maxime nocet.
Post diagnostionem biopsy, curatio proprie est per remotionem chirurgicam. Idque excidere potest, si exiguus cancer est; Si cancer non parvus est, plerumque chirurgica Mohs commendatur.
Carcinoma basalis cellulae saltem 32% omnium carcinomata in globally computat. Carcinomata cutis praeter melanoma circiter 80% sunt carcinomata basali-cellaria. In Civitatibus Foederatis, circiter 35% mares albas et 25% feminarum albarum, afficiuntur carcinomate cellula basali aliquando in vita sua.
○ Diagnosis et curatio
#Dermoscopy
#Skin biopsy
#Mohs surgery